V. Lucet

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease

Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia

Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of function

Diet and Lifestyle Recommendations Revision 2006

Structure of a mammalian ryanodine receptor

Ventricular arrhythmogenesis: Insights from murine models

Ryanodine receptors and ventricular arrhythmias: Emerging trends in mutations, mechanisms and therapies

Effects of Electrophysiologic‐Guided Therapy with Class IA Antiarrhythmic Drugs on the Long‐Term Outcome of Patients with Idiopathic Ventricular Fibrillation with or without the Brugada Syndrome

Mode of onset of torsade de pointes in congenital long QT syndrome

Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca2+ release channel

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

A Missense Mutation in a Highly Conserved Region of CASQ2 Is Associated with Autosomal Recessive Catecholamine-Induced Polymorphic Ventricular Tachycardia in Bedouin Families from Israel

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

Exercise Standards for Testing and Training

The Use of Induced Pluripotent Stem Cells in Drug Development

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Ventricular Arrhythmias in the Absence of Structural Heart Disease

A meta-analysis of heart rate variability and neuroimaging studies: Implications for heart rate variability as a marker of stress and health

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Ventricular fibrillation in six adults without overt heart disease

Sudden cardiac death and channelopathies: a review of implantable defibrillator therapy

PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses

Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia

Reflex control of immunity

Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia

Myocarditis

Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome

Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia

Protecting the myocardium: A role for the β2 adrenergic receptor in the heart

Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases

The role of vagal function in the risk for cardiovascular disease and mortality

Task Force on Sudden Cardiac Death of the European Society of Cardiology

A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel

β-adrenergic action on wild-type and KPQ mutant human cardiac Na+ channels: shift in gating but no change in Ca2+: Na+ selectivity

Midterm experience with implantable cardioverter-defibrillators in children and young adults

FKBP12.6 Deficiency and Defective Calcium Release Channel (Ryanodine Receptor) Function Linked to Exercise-Induced Sudden Cardiac Death

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

Sudden cardiac death and polymorphous ventricular tachycardia in pationts with normal QT intervals and normal systolic cardiac function

Catecholaminergic Polymorphic Ventricular Tachycardia

Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes

Idiopathic ventricular tachycardia in infancy and childhood

Electrophysiologic substrate of torsade de pointes: Dispersion of repolarization or early afterdepolarizations?

Part 8: Advanced life support

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

Guidelines on management (diagnosis and treatment) of syncope

Summary of Recommendations

Intravenous Epinephrine Infusion Test in Diagnosis of Catecholaminergic Polymorphic Ventricular Tachycardia

The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases

Myocarditis

Cardiac excitation–contraction coupling

Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients.

Improving survival from sudden cardiac arrest: the "chain of survival" concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee, American Heart Association.

Exercise Testing in Nonatherosclerotic Heart Disease

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease

Exercise and Physical Activity for Older Adults

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Magnesium in Man: Implications for Health and Disease

β₁-Receptors increase cAMP and induce abnormal Ca_i cycling in the German shepherd sudden death model

Recommendations for Physical Activity and Recreational Sports Participation for Young Patients With Genetic Cardiovascular Diseases

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Abnormal Calcium Signaling and Sudden Cardiac Death Associated With Mutation of Calsequestrin

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene

Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia

Brugada Syndrome: Report of the Second Consensus Conference

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell–Based Regeneration

Sudden Cardiac Death

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Physical Activity and Public Health in Older Adults

Part 8: Post–Cardiac Arrest Care

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Absence of Calsequestrin 2 Causes Severe Forms of Catecholaminergic Polymorphic Ventricular Tachycardia

Molecular Basis of Arrhythmias

Heart Rate Variability

Heart rate variability: Standards of measurement, physiological interpretation, and clinical use

Diabetic Autonomic Neuropathy

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram

Expert consensus document on ?-adrenergic receptor blockersThe Task Force on Beta-Blockers of the European Society of Cardiology

2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia

Paroxysmal Vagal Overactivity, Apparent Life-Threatening Event and Sudden Infant Death

[Long term course of catecholaminergic polymorphic ventricular tachycardia in children. Apropos of 20 cases with an 8 year-follow-up].

Possible Mechanisms of the Arrhythmias in the Long QT Syndrome

Catecholaminergic Polymorphic Ventricular Tachycardia in Children

[The autonomic nervous system in sudden infant death syndrome. Analysis of heart rate and sinusal variability on Holter monitoring of infants who died].